Clinical TrialsSearch results
Number of results: 521
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
- Metastatic gastric cancer (Advanced or recurrent gastric cancer)
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- Phase II study of docetaxel and S-1 as neoadjuvant chemotherapy + gastrectomy for cStage IIIa-IIIb(IV) resectable gastric cancer
- clinical stage IIIa-IIIb(IV) gastric cancer
- Dept. of Surgery and Science, Kyushu University
- 2007-11-05
Other
- Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29
Other
- Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-05-04
Other
- Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704)
- non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2009-08-01
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
- All patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).
- West Japan Oncology Group
- 2005-08-22
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18